EcoR1 Capital, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Immunome Inc. Common Stock (IMNM)

Filing Manager
EcoR1 Capital, LLC
Reporting Manager
EcoR1 Capital, LLC
Symbol
IMNM
Shares outstanding
86,796,064 shares
Disclosed Ownership
4,079,415 shares
Ownership
4.7%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 14:04:48 UTC
Date of event
31 Mar 2025

Sponsored

Quoteable Key Fact

"EcoR1 Capital, LLC disclosed 4.7% ownership in Immunome Inc. Common Stock (IMNM) on 31 Mar 2025."

Quick Takeaways

  • EcoR1 Capital, LLC filed SCHEDULE 13G/A for Immunome Inc. Common Stock (IMNM).
  • Disclosed ownership: 4.7%.
  • Date of event: 31 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 15 May 2025, 14:04.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
EcoR1 Capital, LLC 4.7% 4,079,415 0 4,079,415 /s/ Oleg Nodelman Manager
Oleg Nodelman 4.7% 4,079,415 0 4,079,415 /s/ Oleg Nodelman Reporting person
EcoR1 Capital Fund Qualified, L.P. 4.4% 3,847,477 0 3,847,477 /s/ Oleg Nodelman Manager of the General Partner, EcoR1 Capital, LLC